
T2 Biosystems TTOO
Quartalsbericht 2024-Q3
hinzugefügt 14.11.2024
T2 Biosystems DSO 2011-2026 | TTOO
DSO Jährlich T2 Biosystems
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 91.3 | 60 | 66.6 | 103 | 124 | 62.1 | 36.5 | 29.3 | 47.9 | 617 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 617 | 29.3 | 124 |
DSO Vierteljährlich T2 Biosystems
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75.8 | 67.8 | 66.4 | - | 74.4 | 60.4 | 76 | - | 53.3 | 54.7 | 59.9 | - | 50.4 | 54.6 | 59.9 | - | 88.7 | 182 | 142 | 84 | 154 | 143 | 118 | 90.9 | 66.1 | 41.5 | 44.5 | 25.7 | 38.5 | 44.6 | 38.5 | 32.8 | 27.5 | 30.1 | 29 | 33.3 | 32.1 | 59.7 | 138 | 154 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 182 | 25.7 | 72 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
94.7 | $ 1.63 | -1.52 % | $ 2.17 M | ||
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
63.8 | $ 115.26 | -0.31 % | $ 35 B | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
Illumina
ILMN
|
61.3 | $ 126.83 | -1.31 % | $ 20.2 B | ||
|
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
49.2 | $ 24.61 | -1.48 % | $ 684 M | ||
|
Lantheus Holdings
LNTH
|
80.5 | $ 82.83 | -1.52 % | $ 5.59 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 16.85 | -1.52 % | $ 377 M | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 22.39 | 2.47 % | $ 1.19 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
Precipio
PRPO
|
21.1 | $ 31.9 | 2.9 % | $ 51.2 M | ||
|
Personalis
PSNL
|
55.8 | $ 5.43 | -8.89 % | $ 322 M | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Senseonics Holdings
SENS
|
10.3 | $ 7.15 | -1.72 % | $ 298 M | ||
|
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 15.19 | -2.63 % | $ 459 M | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 470.48 | 0.52 % | $ 177 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 166.04 | -3.03 % | $ 8.23 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Trinity Biotech plc
TRIB
|
87.2 | $ 0.63 | -2.99 % | $ 61.9 M | ||
|
Guardant Health
GH
|
46.1 | $ 83.59 | -5.55 % | $ 10.5 B | ||
|
Twist Bioscience Corporation
TWST
|
44.5 | $ 59.97 | -1.7 % | $ 3.59 B | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
66.9 | $ 1.93 | - | $ 8.54 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 415.77 | -1.33 % | $ 12 B | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Biomerica
BMRA
|
57.7 | $ 2.19 | 0.23 % | $ 5.03 M | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 101.26 | -1.89 % | $ 8.35 B | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 260.26 | -1.2 % | $ 21.7 B | ||
|
Neogen Corporation
NEOG
|
66.6 | $ 9.22 | -2.49 % | $ 2 B | ||
|
NeoGenomics
NEO
|
77.7 | $ 8.96 | 4.01 % | $ 1.15 B | ||
|
Myriad Genetics
MYGN
|
52.3 | $ 4.88 | 1.04 % | $ 452 M | ||
|
Natera
NTRA
|
81.5 | $ 202.48 | -0.93 % | $ 19.9 B | ||
|
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 195.25 | -0.7 % | $ 21.7 B | ||
|
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M | ||
|
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M |